[Progress on the drug therapy for diabetic microangiopathies: aldose reductase inhibitor].
Hotta
Nigishi
N
Chubu Rosai Hospital.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors* / Q000235:genetics; D000818:Animals; D002986:Clinical Trials as Topic; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000209:etiology; D015195:Drug Design; D006801:Humans; D048289:Imidazolidines / Q000494:pharmacology / Q000627:therapeutic use; D011108:Polymers / Q000378:metabolism; D011110:Polymorphism, Genetic; D011719:Pyrazines / Q000494:pharmacology / Q000627:therapeutic use*; D012236:Rhodanine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D013141:Spiro Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D053778:Thiazolidines
D048289:Imidazolidines; D011108:Polymers; D011719:Pyrazines; D013141:Spiro Compounds; D053778:Thiazolidines; C024617:polyol; C038131:epalrestat; D012236:Rhodanine; C077139:fidarestat; D000449:Aldehyde Reductase; C115070:ranirestat